We have observed
8 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 02, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHOD FOR INCREASING ETEC CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND PRODUCTS OBTAINABLE THEREOF
ZSCAN4 AS A MARKER FOR PANCREATIC STEM CELLS AND PROGENITOR CELLS AND USE THEREOF
DETECTION OF SAXITOXIN-PRODUCING DINOFLAGELLATES
MUTANT CELLS FOR PROTEIN SECRETION AND LIGNOCELLULOSE DEGRADATION
COMPOSITIONS AND METHODS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS
Inhibitors of focal adhesion kinase
USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS
ENHANCED CELLODEXTRIN METABOLISM